Skip NavigationSkip to Content

Inhibition of Ribosome Biogenesis in vivo Causes p53-Dependent Death and p53-Independent Dysfunction

  1. Author:
    Cho, Charles J
    Nguyen, Thanh
    Rougeau, Amala K
    Huang, Yang-Zhe
    To, Sarah
    Lin, Xiaobo
    Thalalla Gamage,Supuni
    Meier,Jordan
    Mills, Jason C
  2. Author Address

    Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX. Electronic address: Charles.Cho@bcm.edu., Division of Gastroenterology, Department of Medicine, Washington University School of Medicine, St. Louis, MO., Chemical Biology Laboratory, National Cancer Institute, National Institutes of Health, Frederick, MD., Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX. Electronic address: Jason.Mills@bcm.edu.,
    1. Year: 2025
    2. Date: Mar 11
    3. Epub Date: 2025 03 11
  1. Journal: Cellular and Molecular Gastroenterology and Hepatology
    1. Pages: 101496
  2. Type of Article: Article
  3. Article Number: 101496
  1. Abstract:

    While it is well-known that ribosomes are critical for cell function, and their synthesis (known as ribosome biogenesis; "RiBi") is energy-intensive, surprisingly little is known about RiBi in vivo in adult tissue. Using a mouse model with conditional deletion of Nat10, an essential gene for RiBi and subsequent translation of mRNA, we investigated the effects of RiBi blockade in vivo, with a focus on pancreatic acinar cells during homeostasis and tumorigenesis. We observed an unexpected latency of several weeks between Nat10 deletion and onset of structural and functional abnormalities and p53-dependent acinar cell death. While deletion of Trp53 rescued acinar cells from apoptotic cell death, Nat10?/?; Trp53?/? acinar cells remained morphologically and functionally abnormal. Deletion of Nat10 in acinar cells blocked Kras-oncogene-driven pancreatic ductal adenocarcinoma, regardless of Trp53 mutation status. Together, our results provide initial insights into how differentiated cells respond to defects in RiBi and translation in vivo in various physiological contexts. Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.

    See More

External Sources

  1. DOI: 10.1016/j.jcmgh.2025.101496
  2. PMID: 40081569
  3. PII : S2352-345X(25)00037-2

Library Notes

  1. Fiscal Year: FY2024-2025
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel